[Cellular reactions of immunocytes against prostate carcinoma and their clinical relevance (author's transl)].
The body's intrinsic defence against cancer depends mainly on cells of the lymphatic and reticulo-endothelial system, recognisable by an infiltration of mononuclear round cells into tumour tissue. In contrast to bladder carcinoma, cellular immune defence reactions to prostate carcinoma are only regularly observed when the tumour has broken through the capsule, or when distant metastases are present. This observation may be explained by the absence of an intrinsic lymphatic vascular system in the prostate. In contrast to bladder carcinoma, cellular immune defence reactions have no clinical significance in the later stages of prostate carcinoma.
D000230:Adenocarcinoma / Q000276:immunology*; D000328:Adult; D000368:Aged; D000921:Antibody-Producing Cells; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000276:immunology*
Zelluläre Immunabwehrreaktionen auf Prostatakarzinomgewebe und ihre klinische Relevanz.